Relyvrio
Payments companies reported to CMS as associated with Relyvrio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Relyvrio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Relyvrio
These are the largest totals companies reported as associated with Relyvrio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sabrina Paganoni | Charlestown, MA | Physical Medicine & Rehabilitation | $73,636.13 |
| Gary Pattee | Lincoln, NE | Neurology (Psychiatry & Neurology) | $58,974.68 |
| Jeffrey Rosenfeld | Fresno, CA | Neuromuscular Medicine (Psychiatry & Neurology) | $36,081.21 |
| Lauren Brown | Portland, OR | Gerontology (Nurse Practitioner) | $26,062.11 |
| Richard Bedlack | Durham, NC | Neurology (Psychiatry & Neurology) | $21,779.53 |
| Bernhardt Zeiher | Port Clinton, OH | $21,518.91 | |
| John Novak | Westerville, OH | Clinical Neurophysiology | $19,798.65 |
| Said Beydoun | Los Angeles, CA | Clinical Neurophysiology | $16,445.44 |
| Michael Elliott | Seattle, WA | Neurology (Psychiatry & Neurology) | $15,541.94 |
| Nithya Mathai | Boynton Beach, FL | Nurse Practitioner | $13,693.60 |
Prescribed Relyvrio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.